The Cooper Companies Inc. (NYSE: COO) has closed the $1.2 billion acquisition of Sauflon Pharmaceuticals Ltd. and a new $700 million loan.

Sauflon, headquartered in Twickenham, England, manufactures and distributes soft contact lenses.

Cooper also closed a $700 million three-year senior unsecured term loan which it will use to fund the acquisition. The loan matures Aug. 4, 2017.

Cooper, headquartered in Pleasanton, California, is a medical device company that operates vision and surgical businesses.

The acquisition follows the purchase of contact-distribution company 1-800 Contacts by private equity firm Thomas H. Lee Partners in January.

 

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.